Literature DB >> 27543315

The ubiquitin family meets the Fanconi anemia proteins.

Xavier Renaudin1, Leticia Koch Lerner2, Carlos Frederico Martins Menck2, Filippo Rosselli3.   

Abstract

Fanconi anaemia (FA) is a hereditary disorder characterized by bone marrow failure, developmental defects, predisposition to cancer and chromosomal abnormalities. FA is caused by biallelic mutations that inactivate genes encoding proteins involved in replication stress-associated DNA damage responses. The 20 FANC proteins identified to date constitute the FANC pathway. A key event in this pathway involves the monoubiquitination of the FANCD2-FANCI heterodimer by the collective action of at least 10 different proteins assembled in the FANC core complex. The FANC core complex-mediated monoubiquitination of FANCD2-FANCI is essential to assemble the heterodimer in subnuclear, chromatin-associated, foci and to regulate the process of DNA repair as well as the rescue of stalled replication forks. Several recent works have demonstrated that the activity of the FANC pathway is linked to several other protein post-translational modifications from the ubiquitin-like family, including SUMO and NEDD8. These modifications are related to DNA damage responses but may also affect other cellular functions potentially related to the clinical phenotypes of the syndrome. This review summarizes the interplay between the ubiquitin and ubiquitin-like proteins and the FANC proteins that constitute a major pathway for the surveillance of the genomic integrity and addresses the implications of their interactions in maintaining genome stability.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA repair; Fanconi anemia; NEDD8; Ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27543315     DOI: 10.1016/j.mrrev.2016.06.004

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  9 in total

Review 1.  The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.

Authors:  Lisa Dwane; William M Gallagher; Tríona Ní Chonghaile; Darran P O'Connor
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

Review 2.  Emerging functions of the Fanconi anemia pathway at a glance.

Authors:  Rhea Sumpter; Beth Levine
Journal:  J Cell Sci       Date:  2017-08-15       Impact factor: 5.285

Review 3.  Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  The Ubiquitin Ligase (E3) Psh1p Is Required for Proper Segregation of both Centromeric and Two-Micron Plasmids in Saccharomyces cerevisiae.

Authors:  Meredith B Metzger; Jessica L Scales; Mitchell F Dunklebarger; Allan M Weissman
Journal:  G3 (Bethesda)       Date:  2017-11-06       Impact factor: 3.154

5.  CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.

Authors:  Tamara Codilupi; Doreen Taube; Hanspeter Naegeli
Journal:  BMC Cancer       Date:  2019-11-05       Impact factor: 4.430

6.  Novel diagnostic approaches for Fanconi anemia (FA) by single-cell sequencing and capillary nano-immunoassay.

Authors:  Lixian Chang; Xingjie Gao; Guangzhen Ji; Xuelian Cheng; Yao Zou; Tao Cheng; Weiping Yuan; Xiaofan Zhu
Journal:  Blood Sci       Date:  2021-01-21

Review 7.  Writing Histone Monoubiquitination in Human Malignancy-The Role of RING Finger E3 Ubiquitin Ligases.

Authors:  Deborah J Marsh; Kristie-Ann Dickson
Journal:  Genes (Basel)       Date:  2019-01-18       Impact factor: 4.096

8.  Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program.

Authors:  Anne Helbling-Leclerc; Françoise Dessarps-Freichey; Caroline Evrard; Filippo Rosselli
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 9.  The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.

Authors:  Xavier Renaudin; Filippo Rosselli
Journal:  Genes (Basel)       Date:  2020-05-25       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.